Global Opioid Dependence Treatment Market is Projected to Value Over US$ 3 Billion by the End of 2026

  • 18 Jun 2019

The global opioid dependence treatment market is prognosticated to value over US$ 3 billion by the end of 2026 and developing at a CAGR of over 10% during the forecast period, 2019 to 2026.   

Opioid dependence combines aspects of opioid addiction and opioid use disorder. Opioid drug addiction treatments are provided in several different settings by using a number of behavioural and pharmacological approaches. Ongoing treatments are situated around maintenance therapy with buprenorphine, opioid agonist and methadone, or naltrexone. In the case of an overdose, naloxone can be used as an acute rescue medication, and in some cases, it is used in combination with buprenorphine. Naloxone can be utilized as a subtle relief medication in an overdose situation. Naloxone can be blended with buprenorphine as well. 
The US government has proposed several steps to offer policies which would curb the rise in usage of opioid. The initiation of four late-stage pipeline agents will fuel the growth of the market. Changing life science patterns and increasing utilization of narcotics in pain management is a major cause of opioid dependency.
Presently available treatment options are targeted towards detoxification and long-term agonist maintenance. At present, pharmacological therapies are proven effective over alternative therapies and boosted the growth of the market. Further, increasing dependency on pharmacological therapies by physicians is expected to fuel the demand during the forecast period. According to US NIH, 2 million among the US population and 15 million across the globe have been affected by opioid dependency. In 2016, more than 35,000 deaths were caused by misuse of opioids. According to the National Institute on Drug Abuse,  nearly 2.3 million people in the U.S. were addicted to prescription opioids. 47,000 people died of an overdose of an opioid. Such incidents have hindered the growth of the market. This has led to US government announce addiction of opioid as public health emergency which has further restrained the growth of the market.
North America is a major shareholder in the global market due to increasing prevalence. The US is a major shareholder in the global market and it is expected to remain the same throughout the forecast period. It is followed by the Europe region due to high adoption among the end user segment. Latin America is a fast-growing region in the global market due to the high prevalence of patient population. It is followed by the Asia Pacific and Rest of World market accounts a small fraction of the global market and expected to remain the same throughout the forecast period.

Opioid Dependence Treatment market players include Reckitt Benckiser Pharmaceuticals Inc., Mylan, Dr. Reddy's Laboratories, ADAPT Pharma, Inc., LUMITOS AG, and others.

Opioid Dependence Treatment Market Restraints:
●    Growing number of deaths due to prescription of opioid
●    The US government declaring opioid addiction as a public health emergency


Opioid Dependence Treatment Market Segmentation
By Drug Class

●    Buprenorphine
●    Naloxone
●    Methadone

By Sales Channel
●    Retail Pharmacies
●    Hospitals
●    Rehabilitation Centres

By Region:
●    North America
●    Latin America
●    Europe
●    Asia Pacific
●    Rest of the World

Competitive Landscape:
●    Tier 1 players- established companies in the market with a major market share
●    Tier 2 players 
●    Emerging players which are growing rapidly 
●    New Entrants  

FutureWise Key Takeaways: 
•    Growth prospects
•    SWOT analysis 
•    Key trends 
•    Key data-points affecting market growth 

Objectives of the Study: 
•    To provide with an exhaustive analysis on the Global Opioid Dependence Treatment Market by drugs, by sales channel, and by Region
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
•    Profiling of companies to evaluate their market shares, strategies, financials and core competencies  


Get unlimited analyst support and customise this study further to your requirements, contact